Discover a new way to find and share stories you'll love… Learn about Reading Desk

All Blogs / Industries / Medical / Pharmaceutical / Popular

Cuckoo For Publishing Fees

The scam publishers line up, once again, to publish a manuscript full of gibberish. This one is titled "Cuckoo For Cocoa Puffs", and is authors, ostensibly, by Pinkerton LeBrain and Orson Welles. Seventeen "publishers" have acceptedShow More Summary

Flex Pharmaceuticals Is Testing What?

Flex Pharmaceuticals went public the other day, another in the string of IPOs in the biopharma world. This is also another Christopher Westphal company - he was a founder of Sirtris, about which much ink and many pixels (here and elsewhere) have been shed, and more recently founded Verastem (who also went public with alacrity). Show More Summary

Expensive Placebos Work Better

The placebo effect weirds everyone out. I think we can say that without much fear of contradiction. It seems like magic, the fact that just thinking that you're getting some treatment of benefit can have actual benefits. Magic, though, it is not. Show More Summary

The ACS Becomes Invisible (But Not For Long)

Here's what looks like a weird publishing decision: the American Chemical Society seems to have blocked search engines for its publications. Try it: type "JACS" into Google, and you'll no longer get the journal's page showing up in the search results. Show More Summary

Refold Those Proteins

Anyone who expresses and purifies proteins for a living has had to do plenty of refolding over the years. Some proteins are rock-solid rock stars - carbonic anhydrase, say. You can do most anything to them and they just shrug it off....Show More Summary

Interview Question Psy-Ops

Chemjobber picks up here on an interesting letter to C&E News. What do you do, on a job interview, when your interviewer says something that's obviously wrong? In my case, however, there was not an explicit question being asked. Rather,...Show More Summary

NEW: 2014-15 Economic Report on Retail, Mail, and Specialty Pharmacies

I am pleased to announce the availability of our new report: the 2014-15 Economic Report on Retail, Mail, and Specialty Pharmacies. We’re offering special discounts if you order before February 15, 2015. This year’s report—our sixth edition—has been completely updated, revised, reorganized, and expanded. Show More Summary

Inside the Dr. Oz PR Machine

I mentioned last fall that the Federal Trade Commission had gone after an egregiously faked-up "study" that was being used to sell green coffee bean extract as some sort of miracle weight-loss drug on the Dr. Oz show. The agency hasShow More Summary

OK, You San Diego People

I've already been hearing from people out on the West Coast about how it's seventy-odd Fahrenheit out there. My first thought was "It's five AM out in San Diego; why aren't you asleep rather than looking at the thermometer?" But as for the Cambridge/Boston biopharma world, yeah, we're mostly at home today. Show More Summary

News Roundup, January 2014: AmerisourceBergen, Walgreens Boots Alliance, Express Scripts, and New 340B Abuses

Winter has arrived at our worldwide headquarters. While you are snowed in, please enjoy this month’s hand-picked artisanal selection of articles from the Drug Channels universe. Meet Ornella Barra, the Walgreens Alliance Boots Exec Joining...Show More Summary

India's GVK Accused of Systematic Fraud

This does not look good at all. The European Medicines Agency (EMA) has accused the large Indian generic company (and outsourcing contractor) GVK of widespread systematic fraud. According to this press release, the agency investigated...Show More Summary

Tolerant Chemistry: Be Glad of It

Like a lot of other scientists in the Northeast today, I'm getting things in the lab ready for me not being there tomorrow. (I just ran into a colleague who didn't know that we're set to get two to three feet of snow, distributed by 50 mile-per-hour winds, over the next 36 hours, and he was not happy to get the news from me). Show More Summary

When It Comes to Social Media, Pharma Tells Patients: "Do As We Say, Not As We Do"

Weeding out unsavory, "offensive," or spammy comments is a fact of social media life that has to be dealt with. In general, pharmaceutical companies avoid dealing with comments on social media sites like Facebook and Youtube, although...Show More Summary

Are New Biopharmas Being Formed Quickly Enough?

So we've been having an extraordinary bull market for new biopharma companies - just look at the number that have gone public the last few months. (The past two years have beaten the numbers put up in the previous ten!) And it's notShow More Summary

Reimbursement and Contracting

Reimbursement and Contracting February 24-26, 2015 / Philadelphia, PAAfter a dynamic debut event, CBI’s Reimbursement and Contracting event is back to provide bio/pharmaceutical manufacturers with best practices to optimize commercial contracting and pricing strategies to ensure product success in an ultra competitive and evolving healthcare system. Show More Summary

GSK Cuts Back in China (?)

Here's a report that GSK is cutting back severely in China - 1,000 workers during the first part of this year. seems to be first out with this story; others are quoting them. They refer to "sources close to the company", apparently employees who have already had word of the cutbacks. Show More Summary

Weekly Roundup 1.23.15

It seems 2015 is moving even faster than 2014 as we prepare for the last week of January even though it feels as if the holidays were only last week. It has been that time of year for reflection, looking … Continue reading ?

Elizabeth Warren's "Pharma Swear Jar" Idea

Elizabeth Warren has come out with a proposal for what she's calling a "pharmaceutical swear jar". Once a drug company had been fined, this bill would earmark a percentage of their profits over a multiyear period for use in NIH funding. Show More Summary

Transparency is Good in Theory, But Not in Practice

I attended SMi's Social Media in the Pharmaceutical Industry conference this week and, as usual whenever I attend these conferences in the UK, I meet some very interesting people and get a new perspective on important issues that usually are not discussed in the U.S. Take ethics, for example. Show More Summary

Copyright © 2011 Regator, LLC